CAIR LGL

What CAIR LGL does

CAIR LGL is a French medical device manufacturer founded in 1987 by Georges Gaston Lopez and his son Georges Antoine Lopez. The company designs, develops, manufactures, sterilizes, and commercializes single-use sterile medical devices for hospitals and healthcare facilities, organized across four therapeutic verticals: infusion (anchored by the proprietary Neutraclear™ bidirectional needleless injection valve, SPYDER multi-way extension lines in 2 to 6-way configurations, stopcocks, manifolds, and the DOSICAIR flow regulator), chemotherapy (the CHEMO-CAIR line covering dose preparation, bag preparation, administration sets, and rinsing sets for cytotoxic drug handling), enteral nutrition (the NUTRICAIR™ Enteral line with ENFit™ standardized connectors for feeding tubes, syringes, and hydration tubing), and suction-ventilation (including Salem-type naso-gastric tubes, mucus extractors, and vacuum control systems). The operating model is vertically integrated and B2B: products are sold through direct institutional sales from the Lissieu headquarters to hospitals and through wholly-owned subsidiaries in Belgium (Cair Belgium SRL, Liège), Spain (Laboratorios CAIR España S.L.U, Madrid), and Italy (CAIR ITALIA, Teolo), with a commercial office in Singapore supporting international reach. Production is conducted in-house at two French sites (Lissieu and Saint Laurent de Chamousset in the Rhône department) and a site near Sousse, Tunisia, with a logistics facility in Arnas, France. The company carries ISO 13485:2016, ISO 11135:2014, and CE2797 markings under G-MED certification, and is a member of French Healthcare and SNITEM. CAIR LGL is a privately held Société Anonyme with a registered capital of €11,116,980 and reported headcount of 251-500 employees; no revenue figures, funding rounds, or external ownership stakes are disclosed in the available data.

Name

CAIR LGL

Legal name

Cair LGL, Société Anonyme

Website

https://cairlgl.com

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

101–250 employees

Short description

CAIR LGL designs, manufactures, and distributes single-use sterile medical devices for infusion, chemotherapy, enteral nutrition, and suction-ventilation, selling directly to hospitals and through wholly-owned subsidiaries in Belgium, Spain, Italy, and Singapore.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAHAIAH

Infusion Sets, Catheters & Pump Consumables

Healthcare & Life Sciences/Medical Devices & Diagnostics/Drug Delivery Devices (Injectors, Pumps, Inhalers)

SECONDARYHLAHADAM

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment

SECONDARYIMALAIAB

Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers)

Industrials, Manufacturing & Construction/Packaging & Containers/Pharmaceutical & Medical Packaging

Keywords

• Sterile medical devices
• Infusion therapy products
• Chemotherapy administration devices
• Enteral nutrition devices
• Suction ventilation equipment

Headquarters

HQ city

Lissieu

HQ country

France

HQ region

Europe

Offices8 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Single-use sterile medical device sales: CAIR LGL generates revenue through the manufacture and sale of single-use sterile medical devices. Products are sold as consumable medical supplies to healthcare facilities, hospitals, and healthcare professionals across infusion, chemotherapy, nutrition, and suction-ventilation applications. Devices are sold through direct sales to institutions and via subsidiary distribution networks in European markets.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels1 record

Core offering

CAIR LGL designs, develops, manufactures, sterilizes, and distributes single-use sterile medical devices for hospitals and healthcare facilities. Its portfolio spans four therapeutic areas: infusion (needleless valves, extension lines, flow regulators, stopcocks), chemotherapy (CHEMO-CAIR dose preparation, bag preparation, and administration sets), nutrition (NUTRICAIR enteral feeding with ENFit connectors), and suction-ventilation (gastric suction probes, mucus extractors, vacuum control systems).

Product overview

CAIR LGL is a French medical device manufacturer with over 30 years of experience developing, designing, and manufacturing single-use sterile medical devices. The company's product portfolio is organized into four main therapeutic areas: (1) Infusion solutions featuring the proprietary Neutraclear™ bidirectional needleless injection valve system, Spyder multi-way extension lines, stopcocks, manifolds, Dosicair flow regulators, and various extension lines; (2) Chemotherapy (CHEMO-CAIR) products including dose preparation, bag preparation, administration sets, and Y-sets; (3) Nutrition products under the Nutricair™ Enteral brand with ENFit™ connectors, encompassing feeding tubes, syringes, accessories, and hydration tubing; and (4) Suction-Ventilation equipment including suction tubing, vacuum control systems, mucus extractors, and ventilation devices. The company also offers operating room/patient reconstruction products such as surgical coverings and warming equipment. CAIR LGL operates production facilities in France (Lissieu and Saint Laurent de Chamousset) and Tunisia, with subsidiaries in Belgium, Spain, and Italy.

Differentiator

Problem solved

Functional benefit

Brands

• Neutraclear™: Bidirectional needleless injection valve - a transparent closed system that guarantees neutrality of movement and prevention of infectious risks
• CHEMO-CAIR
• NUTRICAIR™ Enteral
• Dosicair
• SPYDER

Products and services

• Neutraclear™ Bidirectional Needleless Injection Valve

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered minor.

• French HealthcareminorOthersCAIR LGL is a member of French Healthcare, a national initiative supporting French healthcare companies in their international development.
• SNITEM (Syndicat National de l'Industrie des Technologies Médicales)minorOthersCAIR LGL is a member of SNITEM, the French medical technologies industry association representing medical device manufacturers in France.
• IGL GroupminorOthersCAIR LGL shows IGL Group as a partner on their presentation materials, suggesting a collaborative relationship in the healthcare sector.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Vygon: Vygon is a French-headquartered, family-owned manufacturer of single-use medical devices for infusion, neonatology, and enteral nutrition—directly mirroring CAIR LGL's four-vertical portfolio, geography, and SME scale. As one of CAIR LGL's closest like-for-like competitors in French and European hospital accounts, it is the most comparable direct peer.
• ICU Medical: ICU Medical (which acquired Smiths Medical) is a US-listed pure-play in IV therapy, needle-free connectors, and chemotherapy administration sets, giving it a near-identical product focus to CAIR LGL. As a focused infusion/consumables operator, it is more closely comparable than the diversified majors above.
• Polyflex (Bıçakcılar / Euromedis): Euromedis (France) and Bıçakcılar (Turkey) are European-based manufacturers of single-use sterile medical devices for infusion, suction, and urology, frequently competing in the same regional hospital tenders as CAIR LGL. They are direct SME-scale peers with parallel vertical mixes.

Broad incumbents

• B. Braun: B. Braun is a German-headquartered global medical device major with the leading IV infusion set, needle-free connector, and clinical nutrition portfolios (Infusomat/Space, Sterifill, ENFit-compatible devices). It competes head-to-head with CAIR LGL across infusion and nutrition but operates at substantially larger scale and broader geographic reach.
• Fresenius Kabi: Fresenius Kabi is a German-based global leader in clinical nutrition, IV infusion sets, infusion pumps, and single-use disposables, with a comparable vertical mix to CAIR LGL (infusion, parenteral/oral nutrition, oncology admixture). It is a broad incumbent peer against which CAIR LGL positions its Neutraclear and NUTRICAIR lines.
• Baxter International: Baxter is a US-based medical products major with a deep IV sets, IV solutions, and drug delivery portfolio (Viaflo, Mini-Bag, Clearlink needle-free connectors). It is a broad incumbent peer competing with CAIR LGL on infusion consumables in European hospital tenders.
• Becton Dickinson (BD Medical): BD Medical is a global medical-device incumbent with the BD Nexiva, BD Q-Syte, and BD PosiFlush needle-free/IV consumable lines that directly overlap with CAIR LGL's Neutraclear valve and infusion sets. Its scale, US hospital contracts, and innovation pipeline make it a key benchmark broad incumbent peer.

Regional players

• Primed Medical: Primed Medical is a Turkey-based manufacturer of single-use sterile medical devices (IV sets, syringes, surgical disposables) that frequently supplies European and EMEA hospital tenders, making it a regional Mediterranean comparator to CAIR LGL's France–Tunisia manufacturing axis.

Emerging players

• Sentron Medical: Sentron Medical is a niche European SME focused on flow regulators, infusion rate devices, and IV consumables, overlapping with CAIR LGL's DOSICAIR and infusion product categories. As a smaller specialty player, it represents an emerging-style direct peer.

Others

• STERIS (laboratory and sterilization services): While not a direct manufacturer of CAIR LGL's products, STERIS is a global leader in ethylene oxide sterilization and infection prevention, adjacent to CAIR LGL's ISO 11135-certified in-house sterilization operations. It is an ecosystem/peer comparator relevant to its sterilization backbone.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@cairlgl9326
• LinkedInlinkedin.com/company/cairlgl

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CAIR LGL